The Coalition for Healthcare Communications will host a May 2020 conference on healthcare policy, from the perspective of health marketing & comms pros. Learn more & get the registration link here.
Ninety-five percent of rare diseases lack an FDA-approved treatment. But this is where machine learning and artificial intelligence can help. Intouch and PharmaPhorum take a look at what's possible with this exciting tech.
Intouch execs weigh in on key issues pharma marketers will face in 2020. From data security to the future of marketing technology, to how this year's presidential election will affect the industry, find out what key industry leaders think pharma marketers should focus on.
Intouch has earned many awards over the years, but this time our creative chops get recognition outside the world of pharma. Read on to learn more!
Gen-X women are taking on more caregiving responsibility -- making healthcare decisions not only for their children and spouses, but also for their parents. How can pharma marketers help these "chief healthcare officers" get things done and also have a life for themselves?
The National Institutes of Health defines a rare disease as "a condition that affects fewer than 200,000 people." It also estimates that 25 to 30 million people in the United States is living with one of the ~7,000 known rare diseases, yet treatments are only available for about 5% of those ~7,000! Check out the infographic from MM&M to learn more.
So you’ve made the decision to dump your agency and see what else is out there. Or maybe you’re looking to launch a new pharma product and seeking the best partner to join you in the trenches. Either way, when you’re evaluating new agency partners, it’s a big decision that
Super Bowl LIV was this past Sunday, and while some (okay, most) viewers are there for the game – Go, Chiefs!! -- others tune in for the commercials, which are famously over the top and outrageously expensive to produce. We asked the creative minds at Intouch to weigh in on what worked and what wiped out.
How will pharma marketers be affected by Google's recent proposed changes to how desktop ads are identified in search results? Read on to find out.
When two companies share the responsibility for promoting a drug, there’s always the potential for tension. Visions may not align, priorities may compete, or personalities might not mesh, but by preparing for the alliance with the following tips in mind, you can help smooth the process.